On CNBC’s “Halftime Report Final Trades” on Tuesday, Jason Snipe, creator and primary financial investment officer of Odyssey Capital Advisors, stated he is remaining long on AbbVie Inc. (NYSE: ABBV).
Supporting his view, Guggenheim expert Vamil Divan kept an AbbVie Purchase score on Oct. 20, raising the cost target from $227 to $242.
Jim Lebenthal, partner at Cerity Partners, chose QUALCOMM Incorporated (NASDAQ: QCOM) as his last trade.
According to current news, Satellite interactions business Iridium Communications ( NASDAQ: IRDM) and Qualcomm Technologies have actually incorporated Iridium information services into the Snapdragon Objective Tactical Radio, utilized by the U.S. federal government and authorized allied partners, on Oct. 14.
Do not forget to take a look at our premarket protection here
Stephanie Link, primary financial investment strategist, head of financial investment options and portfolio supervisor at Hightower Advisors, called Aptiv PLC (NYSE: APTV).
Aptiv on Tuesday revealed the launch of its most sophisticated radar innovation yet, developed to fulfill growing need for next-generation sophisticated driver-assistance systems (ADAS).
Joe Terranova, senior handling director at Virtus Financial investment Partners, selected Palo Alto Networks, Inc. (NASDAQ: PANW) as his last trade.
Oppenheimer expert Ittai Kidron, on Oct. 17, kept Palo Alto Networks with an Outperform score and raised the cost target from $225 to $245.
Rate Action:
- AbbVie shares fell 0.3% to close at $231.39 on Tuesday.
- QUALCOMM shares increased 1.1% to close at $168.83 throughout the session.
- Aptiv shares acquired 2.6% to close at $85.59 on Tuesday.
- Palo Alto shares acquired 1.2% to settle at $214.40.
Examine This Out:
Picture: Shutterstock
Market News and Data gave you by Benzinga APIs